Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/1999
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332825A1 Peripheral benzodiazepine receptor ligands
12/02/1999CA2332772A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999CA2329072A1 Human transmembrane proteins
12/01/1999EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999EP0960098A1 Arylsulfonyl hydroxamic acid derivatives
12/01/1999EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999EP0959897A1 Method of regulating nitric oxide production
12/01/1999EP0959880A1 Pharmaceutical formulation
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237162A Indene inhibitors of COX-2
12/01/1999CN1236645A Medicine composition containing osteoinductive protein and dorsalizing factor
12/01/1999CN1236618A Substance for preparing medicine to promote union of bone fracture and its preparing process.
11/1999
11/30/1999US5994569 Useful in the treatment or prevention of vitamin d dependent disorders and of il-12-dependent autoimmune diseases
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999US5994370 Indene compounds having activity as SERMS
11/30/1999US5994367 Method for treating tumors using 2-aryl-naphthyridin-4-ones
11/30/1999US5994351 Antiarthritic agents; anticancer agents; antiulcer agents; enzyme inhibitors
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5993817 Method to ameliorate osteolysis and metastasis
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993786 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999060013A2 Il-6 antagonist peptides
11/25/1999WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059969A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059635A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059608A2 Osteoporosis treatment
11/25/1999WO1999059570A1 Protease inhibitors
11/25/1999WO1999059526A2 Protease inhibitors
11/25/1999WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm)
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999031969A3 Transgenic animal model for degenerative diseases of cartilage
11/25/1999CA2690399A1 Il-6 antagonist peptides
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332531A1 Protease inhibitors
11/25/1999CA2332507A1 Angiostatin receptor
11/25/1999CA2332492A1 Protease inhibitors
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2331318A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999CA2327585A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
11/24/1999EP0958304A1 Nucleotide sequence encoding the cd33-like protein
11/24/1999EP0958287A1 Sulfamide-metalloprotease inhibitors
11/24/1999EP0958277A1 Nitric oxide synthase inhibitors
11/24/1999EP0957943A1 Matrix-free osteogenic devices, implants and methods of use thereof
11/24/1999EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
11/24/1999EP0957922A1 New treatment for joint inflammation
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/24/1999CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
11/24/1999CN1236313A Novel methods
11/24/1999CN1236299A Method of treating post menopausal diseases, including osteoporosis
11/24/1999CN1235980A Human calcitonin analogue
11/24/1999CN1235968A Substituted tricyclics
11/24/1999CN1046735C Steroids for treating menopausal complaints
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/23/1999US5990326 An antiinflammatory agent as inhibitors of leukotriene hydrolase
11/23/1999US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis
11/23/1999US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents
11/23/1999US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
11/23/1999US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/23/1999US5989866 FGF homologs
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith
11/19/1999CA2237915A1 Osteoporosis treatment
11/18/1999WO1999058674A2 Method of inhibiting osteoclast activity
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058524A1 Benzocarbazole and indenoindole derived estrogenic agents
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 820